443 related articles for article (PubMed ID: 6892022)
1. Effect of dapsone on blood lactic and pyruvic acids in leprosy.
Sinha SN; Gupta SC; Bajaj AK; Srivastava NP; Mehrotra TN
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):468-70. PubMed ID: 6892022
[TBL] [Abstract][Full Text] [Related]
2. A study of blood ascorbic acid in leprosy.
Sinha SN; Gupta SC; Bajaj AK; Singh PA; Kumar P
Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):159-62. PubMed ID: 6539308
[TBL] [Abstract][Full Text] [Related]
3. Effect of DDS therapy on blood pyruvate and lactate levels in leprosy patients.
Bharadwaj VP; Sritharan V; Venkatesan K; Ramu G; Desikan KV
Lepr Rev; 1980 Sep; 51(3):237-41. PubMed ID: 7442416
[No Abstract] [Full Text] [Related]
4. Dapsone induced hypohaptoglobinemia in lepromatous leprosy patients.
Sritharan V; Bharadwaj VP; Venkatesan K; Girdhar BK
Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):307-10. PubMed ID: 7198620
[TBL] [Abstract][Full Text] [Related]
5. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
6. Effect of ascorbic acid on blood levels of DDS.
Venkatesan K; Bharadwaj VP; Girdhar BK
Lepr India; 1979 Oct; 51(4):511-4. PubMed ID: 522444
[TBL] [Abstract][Full Text] [Related]
7. Blood DDS levels and acetylation rates of sulphadimidine in leprosy patients.
Balakrishnan S; Ramu G
Lepr India; 1977 Jan; 49(1):59-64. PubMed ID: 330945
[TBL] [Abstract][Full Text] [Related]
8. The nose in lepromatous leprosy; bacteriological and histopathological studies of patients treated with dapsone monotherapy for varying periods of time.
Barton RP; Rees RJ; McDougall AC; Ellard GA
Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):58-67. PubMed ID: 7200473
[TBL] [Abstract][Full Text] [Related]
9. Effect of single dose (1500 mg) rifampicin on infectivity of patients with lepromatous leprosy.
Girdhar BK; Sreevatsa ; Desikan KV
Lepr India; 1980 Jul; 52(3):359-65. PubMed ID: 7206633
[TBL] [Abstract][Full Text] [Related]
10. DDS-resistant infection among leprosy patients in the population of Gudiyatham Taluk, South India. Part 3. Prevalence, incidence, risk factors, and interpretation of mouse foot pad test results.
Almeida JG; Chacko CJ; Christian M; Taylor PM; Fritschi EP
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):366-73. PubMed ID: 6685699
[TBL] [Abstract][Full Text] [Related]
11. Response to dapsone (DDS) monotherapy in leprosy patients of Gudiyatham Taluk, South India: comparison between the 1960s and the 1970s.
Almeida JG; Christian M; Chacko CJ
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):378-8. PubMed ID: 6685701
[TBL] [Abstract][Full Text] [Related]
12. Dapsone resistant leprosy, the western Kenya experience.
Orege PA; Owili DM
Trop Geogr Med; 1985 Jun; 37(2):139-42. PubMed ID: 4035777
[TBL] [Abstract][Full Text] [Related]
13. Effect of dapsone (DDS) on T-cells and their response to PHA and lepromin in tuberculoid leprosy patients.
Kumar B; Ganguly NK; Kaur S; Vaishnavi C; Chakravarti RN
Lepr India; 1983 Jul; 55(3):465-71. PubMed ID: 6606732
[TBL] [Abstract][Full Text] [Related]
14. Follow-up of lepromatous (LL and BL) patients on dapsone (DDS) monotherapy after attainment of smear negativity in Gudiyatham Taluk, South India.
Almeida JG; Christian M; Chacko CJ
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):382-4. PubMed ID: 6685702
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation studies in lepromatous leprosy. Sixth series: effect (on lepra reaction) of supplementing DDS with dexamethasone, methandrostenolone, or mefenamic acid.
Doull JA; Tolentino JG; Guinto RS; Rodriguez JN; Leano LM; Fernandez JV; Rivera JN; Fajardo TT
Int J Lepr Other Mycobact Dis; 1967; 35(2):128-39. PubMed ID: 5338957
[No Abstract] [Full Text] [Related]
16. Blood dapsone levels in leprosy patients treated with acedapsone.
George J; Balakrishnan S
Indian J Lepr; 1986; 58(3):401-6. PubMed ID: 3794408
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of the immune state in leprosy.
Mehra NK; Dasgupta A; Vaidya MC
Lepr India; 1976 Jul; 48(3):231-7. PubMed ID: 15165
[TBL] [Abstract][Full Text] [Related]
18. A comparison of low and conventional dosages of dapsone in the treatment of lepromatous leprosy.
Iyer CG; Balakrishnan S; Ramu G
Lepr India; 1977 Jul; 49(3):372-86. PubMed ID: 592740
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of multiple regimens in leprosy.
Ramu G; Sreevatsa ; Sengupta U; Desikan KV
Lepr India; 1981 Apr; 53(2):190-6. PubMed ID: 6166790
[TBL] [Abstract][Full Text] [Related]
20. The significance of dapsone (DDS)-resistant Mycobacterium leprae in untreated patients.
Almeida JG; Chacko CJ; Christian M
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):374-7. PubMed ID: 6685700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
